Congress Reports

American College of Cardiology
55th Annual Scientific Session
March 11-14, Atlanta

 
 
‹‹‹ Click on the dates to see the daily articles!

Simple physical movements reduce vasovagal syncope episodes: PC-Trial

Physical counterpressure maneuvers reduced the number of episodes of vasovagal syncope and reduced the prodrome in a small study conducted in The Netherlands. This should be “first-line therapy in every patient presenting with vasovagal syncope,” stated Nynke van Dijk, Academic Medical Center-University of Amsterdam.
The Netherlands, in concluding her presentation of the Physical Counterpressure Maneuver Trial (PC-Trial) at the American College of Cardiology meeting. The trial was presented in a new session at the ACC meeting, focusing on smaller, hypothesis-generating clinical trials.

Patients with a history of repeated fainting preceded by a known prodrome were randomly assigned to conventional therapy (education and lifestyle modification; n=117) or conventional therapy plus physical counterpressure (PC; n=106) training in 3 techniques (leg crossing, handgrip exercises, arm-tensing exercises). The mean age was 38 years and 28% were male. The number of lifetime syncopal events was similar in both groups (6); syncopal episodes in the previous 2 years (3); presyncopal events in prior year (4); and period of complaints (7-8 years).

At 14 months, the risk of fainting was reduced with PC (0 vs 0.6 conventional therapy; p<0.01). Syncope recurrence was lower with PC (32% vs 51% conventional therapy; p< 0.01). The number of patients experiencing presyncope prodrome was similar in both groups (82% vs 74%; p=0.12). The time to first recurrence was reduced by 40% with PC patients compared to conventional therapy (p=0.018).

 
Legal
The materials presented here were prepared by independent authors under the editorial supervision of ESH online, and do not represent a publication of the American College of Cardiology. These materials and the related activity are not sanctioned by the American College of Cardiology and do not constitute an official part of that conference. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © ESHonline.org.